These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1685854)

  • 1. Viral and cellular factors influencing HIV tropism.
    Levy JA
    Adv Exp Med Biol; 1991; 300():1-15. PubMed ID: 1685854
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates.
    Mosier DE; Gulizia RJ; MacIsaac PD; Torbett BE; Levy JA
    Science; 1993 Apr; 260(5108):689-92. PubMed ID: 8097595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular activation and human immunodeficiency virus infection.
    Virelizier JL
    Curr Opin Immunol; 1989-1990 Feb; 2(3):409-13. PubMed ID: 2576770
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing concepts in HIV infection: challenges for the 1990s.
    Levy JA
    AIDS; 1990 Nov; 4(11):1051-8. PubMed ID: 1980820
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.
    Nowroozalizadeh S; Månsson F; da Silva Z; Repits J; Dabo B; Pereira C; Biague A; Albert J; Nielsen J; Aaby P; Fenyö EM; Norrgren H; Holmgren B; Jansson M
    J Infect Dis; 2010 Apr; 201(8):1150-4. PubMed ID: 20199244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV: virology and mechanisms of disease.
    King SR
    Ann Emerg Med; 1994 Sep; 24(3):443-9. PubMed ID: 7915889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced rate of disease development after HIV-2 infection as compared to HIV-1.
    Marlink R; Kanki P; Thior I; Travers K; Eisen G; Siby T; Traore I; Hsieh CC; Dia MC; Gueye EH
    Science; 1994 Sep; 265(5178):1587-90. PubMed ID: 7915856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.
    Le Guern M; Levy JA
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):363-7. PubMed ID: 1346069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
    Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
    J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A primer on HIV/AIDS.
    JCN
    J Christ Nurs; 2007; 24(1):14-6; quiz 17-8. PubMed ID: 17283817
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of HIV-1 entry into CD4+ T cells.
    Stein BS; Engleman EG
    Adv Exp Med Biol; 1991; 300():71-86; discussion 87-96. PubMed ID: 1685857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of HIV.
    Kaplan MH
    Infect Dis Clin North Am; 1994 Jun; 8(2):279-88. PubMed ID: 7916357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2.
    Michaels FH; Hattori N; Gallo RC; Franchini G
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
    De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
    J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Jules Bordet Lecture. Immunopathogenesis of HIV infection.
    Fauci AS
    Ann N Y Acad Sci; 1993 Jun; 685():408-19. PubMed ID: 8103314
    [No Abstract]   [Full Text] [Related]  

  • 16. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.
    Pope M; Gezelter S; Gallo N; Hoffman L; Steinman RM
    J Exp Med; 1995 Dec; 182(6):2045-56. PubMed ID: 7500050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences of HIV envelope protein between HIV-1 and HIV-2: possible relation to the lower virulence of HIV-2.
    Sekigawa I; Kaneko H; Neoh LP; Takeda-Hirokawa N; Akimoto H; Hishikawa T; Hashimoto H; Hirose S; Yamamoto N; Kaneko Y
    Viral Immunol; 1998; 11(1):1-8. PubMed ID: 9586692
    [No Abstract]   [Full Text] [Related]  

  • 18. New perspectives on HIV pathogenesis. Viral replication is continuous throughout the course of disease.
    J Assoc Nurses AIDS Care; 1995; 6(4):26-7. PubMed ID: 7495989
    [No Abstract]   [Full Text] [Related]  

  • 19. The AIDS virus. What we know and what we can do about it.
    Wong-Staal F
    West J Med; 1991 Nov; 155(5):481-7. PubMed ID: 1687714
    [No Abstract]   [Full Text] [Related]  

  • 20. The George M. Kober lecture. Basic immunology: the path to the delineation of the immunopathogenic mechanisms of HIV infection.
    Fauci AS
    Trans Assoc Am Physicians; 1988; 101():clx-clxxiii. PubMed ID: 2908369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.